Colin Macaulay
Fundador en Viron Therapeutics, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
James Moodie Rae | M | - |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | 17 años |
Robert Browne | M | - |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Bill James Peck | M | 64 |
University of Alberta
| - |
Grant McFadden | M | - |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | 19 años |
Ronald Kisic | M | - |
University of Alberta
| 8 años |
R. Allford | M | - |
University of Alberta
| 8 años |
Neil Warma | M | 61 |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | 3 años |
Bruce Beynon | M | 60 |
University of Alberta
| 6 años |
Christian Bayle | M | 55 |
University of Alberta
| 5 años |
Miles W. Safranovich | M | - |
University of Alberta
| 9 años |
Raymond Bower | M | - |
University of Alberta
| 4 años |
Kevin V. Sullivan | M | 49 |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | 10 años |
Dale Hildebrand | M | 60 |
University of Alberta
| 7 años |
Kris Smith | M | - |
University of Alberta
| 4 años |
Terry Caelli | M | - |
University of Alberta
| 7 años |
Kam Lun Eric Ng | M | 63 |
University of Alberta
| 4 años |
Cameron R. Fink | M | 55 |
University of Alberta
| 4 años |
John Williams | M | 72 |
University of Alberta
| 4 años |
Tammy DuPerron | F | 63 |
University of Alberta
| 4 años |
David Anderson | M | 54 |
University of Alberta
| 4 años |
Steven James Glover | M | - |
University of Alberta
| 2 años |
Keung Jimmy Chik Wong | M | - |
University of Alberta
| 4 años |
Paul Kristensen | M | - |
University of Alberta
| 4 años |
John Bossio | M | 55 |
University of Alberta
| 4 años |
Da Li Zhang | M | 64 |
University of Alberta
| 1 años |
Kar Loon Quek | M | 61 |
University of Alberta
| 4 años |
Jeffrey Green | M | - |
University of Alberta
| 4 años |
Ben Nyland | M | 54 |
University of Alberta
| 4 años |
Darrell Cotterill | M | - |
University of Alberta
| 4 años |
Bruno Kasper | M | - |
University of Alberta
| 4 años |
Tom Peterson | M | - |
University of Alberta
| 4 años |
Bruce N. Moisey | M | 62 |
University of Alberta
| 4 años |
Scott Carter | M | - |
University of Alberta
| 4 años |
Dwayne William Sorobey | M | 59 |
University of Alberta
| 4 años |
Lisa Doig | F | - |
University of Alberta
| 4 años |
Stephanie Sterling | F | 57 |
University of Alberta
| 4 años |
Conan Taylor | M | - |
University of Alberta
| 4 años |
Russell Edward Wlad | M | - |
University of Alberta
| 4 años |
Martin Vydra | M | - |
University of Alberta
| 3 años |
Richard Roy | M | - |
University of Alberta
| 4 años |
Michael Power | M | - |
University of Alberta
| 4 años |
Kwok Hay Wong | M | 75 |
University of Alberta
| 3 años |
Jugdutt Singh | M | - |
University of Alberta
| 1 años |
Troy G. Tews | M | - |
University of Alberta
| 4 años |
Steve Dobler | M | 60 |
University of Alberta
| 4 años |
Bryce Kremnica | M | - |
University of Alberta
| 4 años |
Doyle Sam | M | - |
University of Alberta
| 4 años |
Louis Picco | M | 58 |
University of Alberta
| 4 años |
Louis Hugo Francescutti | M | - |
University of Alberta
| 3 años |
Michèle Stanners | F | 66 |
University of Alberta
| 3 años |
Arokia Nathan | M | - |
University of Alberta
| 3 años |
Wendy Henkelman | F | 59 |
University of Alberta
| 4 años |
Doug McMillan | M | - |
University of Alberta
| 4 años |
Gregory F. Juneau | M | 57 |
University of Alberta
| 4 años |
Dean Schultz | M | - |
University of Alberta
| 4 años |
Antoinette Boquiren | F | 56 |
University of Alberta
| 4 años |
Michael J. Rusch | M | 78 |
University of Alberta
| 4 años |
Tony Bright | M | - |
University of Alberta
| 4 años |
John Williamson | M | 64 |
University of Alberta
| 4 años |
Terry Tucker | M | - |
University of Alberta
| 4 años |
Philip Collins | M | - |
University of Alberta
| 4 años |
Shane Ebert | M | - |
University of Alberta
| 4 años |
Robert James Maddigan | M | - |
University of Alberta
| 4 años |
Stuart Olley | M | - |
University of Alberta
| 2 años |
Norm A. Gretzinger | M | - |
University of Alberta
| 4 años |
Kerry Kozlowski | F | - |
University of Alberta
| 4 años |
Douglas Bartole | M | 56 |
University of Alberta
| 4 años |
Wendell Zerb | M | 60 |
University of Alberta
| 4 años |
Don Rawson | M | - |
University of Alberta
| 4 años |
Allan Gregory Stepa | M | - |
University of Alberta
| 4 años |
Patrick Stiles | M | - |
University of Alberta
| 4 años |
Mark G. Maybank | M | 53 |
University of Alberta
| 5 años |
Bruce Daniel Beingessner | M | 59 |
University of Alberta
| 4 años |
Robert Foster | M | 65 |
University of Alberta
| 9 años |
Garey James Aitken | M | - |
University of Alberta
| 4 años |
Changxin Li | M | 63 |
University of Alberta
| 3 años |
Sean W. Duffee | M | - |
University of Alberta
| 4 años |
Gordon Robert McCormack | M | 59 |
University of Alberta
| 4 años |
Thorsten Brost | M | - |
University of Alberta
| 4 años |
Michael R. Smillie | M | - |
University of Alberta
| 4 años |
Cheryle Donahue | F | - |
University of Alberta
| 4 años |
John Haylock | M | - |
University of Alberta
| 4 años |
Gregory Francis Kennedy | M | 74 |
University of Alberta
| 4 años |
Cary Pothorin | M | - |
University of Alberta
| 4 años |
Ross McElroy | M | 60 |
University of Alberta
| 4 años |
Monroe Thomas | M | - |
University of Alberta
| 4 años |
Darin Labrenz | M | 58 |
University of Alberta
| 4 años |
Mark Krantz | M | - |
University of Alberta
| 4 años |
Darren Gee | M | 56 |
University of Alberta
| 4 años |
Gregory J. Hansen | M | 58 |
University of Alberta
| 4 años |
Craig Hruska | M | - |
University of Alberta
| 4 años |
Jeffrey G. Sheremeta | M | 52 |
University of Alberta
| 4 años |
Sean M. Brett | M | 58 |
University of Alberta
| 5 años |
Donald Boykiw | M | - |
University of Alberta
| 3 años |
Kevin J. Inman | M | - |
University of Alberta
| 4 años |
Shaun E. Alspach | M | - |
University of Alberta
| 4 años |
Arie B. Prins | M | - |
University of Alberta
| 4 años |
George Chow | M | 62 |
University of Alberta
| 3 años |
Darin R. Coutu | M | 58 |
University of Alberta
| 4 años |
Leanne Geale | F | 59 |
University of Alberta
| 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Canadá | 100 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Colin Macaulay
- Red Personal